Lupus Anticoagulant in Patients with Covid-19. Reply

N Engl J Med. 2020 Nov 5;383(19):1893-1894. doi: 10.1056/NEJMc2027508. Epub 2020 Oct 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiphospholipid Syndrome* / complications
  • Antiphospholipid Syndrome* / drug therapy
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Humans
  • Lupus Coagulation Inhibitor*
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Lupus Coagulation Inhibitor